Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Flightpath Biosciences has raised $8.1M in total funding. The most recent round was Series A. The last funding was announced in February 2023.
Flightpath Biosciences's investors include Michigan Rise, Ann Arbor SPARK, Illumina Accelerator.
Flightpath Biosciences is headquartered in Berkeley, United States.
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Flightpath Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flightpath Biosciences — Funding & Investors." VCBacked, February 15, 2023, https://www.vcbacked.co/company/flightpath-biosciences. Accessed October 28, 2026.
VCBacked. (2023). Flightpath Biosciences — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/flightpath-biosciences
{{cite web |title=Flightpath Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/flightpath-biosciences |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated